To address limitations of standard-of-care KAFOs, a powered-KAFO has been developed. This pilot study examined functional ambulation, balance, and exertion during gait with and without the powered-KAFO.

This pilot clinical trial assessed the feasibility of delivering combination motor learning-based (MLB) therapy and MyoPro® myoelectric upper limb orthosis in a mixed cohort of 13 persons with chronic stroke and traumatic brain injury (TBI). Subjects participated in an In-clinic phase consisting of MLB therapy paired with MyoPro® (1.5 hours twice weekly for 9 weeks) followed by a Home phase (9 weeks). Combined therapy of 27 hours in clinic resulted in impairment changes (Fugl-Meyer Assessment) that were close to those reported previously reported with 150 hours of in-person MLB therapy alone. While most outcomes improved during the in clinic phase and were maintained during the home phase, participation as assessed by CHART improved through both phases. It was feasible and safe to deliver the combination therapy.

Hear about the one-year results obtained from a registry designed to gather real-world effectiveness data from patients fitted with a micro­processor-controlled knee ankle foot orthosis (C-Brace®). Also, discover how results compare between post-stroke subjects versus those with non-stroke diagnoses.

As the evidence in a link between idiopathic toe walking and sensory processing disorders grows, there will be a need for treatment options to adequately address this connection. The purpose of this study was to identify these therapeutic interventions targeting sensory input and compare their efficacy at normalizing equinus gait.